🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE

Recruitingn/aAges any - anyAllFondazione IRCCS Ca' Granda, Ospedale Maggiore Po…
NCT07874139 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational, multicentric prospective study aims to understand the prevalence and burden of antimicrobial resistance (AMR) in people with chronic lung diseases (CLD) across the globe, understanding also geographical variability and the risk factors for acquiring AMR. The primary objective is to understand the prevalence and burden of AMR in CLD both at a local and gloval level. Secondary objectives include: 1) understanding susceptibilities models of high priority pathogens in people with CLD; 2) understanding geographic variability in the prevalence of AMR in CLD; 3) analysing risk factors for AMR in CLD Participants will be recruited

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients of all ages with any chronic lung disease who, for clinical practice, underwent testingof at least one respiratory biological sample (sputum culture; bronchoaspirate; bronchoalveolar lavage; nasal swab; throat swab) within the 12 months prior to the visit. * Patients attending an outpatient clinic or hospitalized during the study period Exclusion Criteria: * Patients who have not signed the informed consent form * Absence of data in the patient record
💊

What it tests

  • Not listed
📍

Where

68 sites
University of Michigan
Ann Arbor, United States
Catholic University Our Lady of Good Counsel
Tirana, Albania
Frankston Hospital
Frankston, Australia
Antwerp University Hospital
Antwerp, Belgium
CHU St Pierre
Brussels, Belgium
AZ Maria Middelares
Ghent, Belgium
Ghent University Hospital
Ghent, Belgium
University Hospital Leuven
Leuven, Belgium

…and 60 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy